8-K: Interlink Electronics Reports Mixed Q4, Eyes 2026 Growth

Interlink Electronics announced its fourth-quarter 2025 financial results, showing a decline in Q4 revenue and increased net loss, but reported full-year revenue growth and reduced annual losses while pursuing strategic growth initiatives.

Summary

• Interlink Electronics reported a 4.5% decrease in fourth-quarter 2025 revenue to $2.85 million, down from $2.99 million in Q4 2024.
• Net loss for Q4 2025 increased to $574,000, compared to a net loss of $413,000 in the prior-year period.
• Full-year 2025 revenue increased by 1.8% to $11.89 million, up from $11.68 million in 2024.
• The company reduced its full-year 2025 net loss to $1.615 million, an improvement from a $1.984 million net loss in 2024.
• Discretionary bonuses of $60,000 and $20,000 were approved for CEO Steven N. Bronson and CFO Ryan J. Hoffman, respectively, for their performance in fiscal year 2025.
• Successfully converted preferred stock into common stock in October 2025, eliminating $400,000 in annual preferred stock dividends.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a moderately positive filing. While Q4 financial performance was weak, the full-year results show reduced losses, and the strategic initiatives in high-growth markets, coupled with the elimination of preferred stock dividends, provide a positive outlook for future organic growth.

Positives

• Began volume production of a custom piezoelectric sensor solution for the rapidly expanding autonomous vehicle market.
• Now shipping a second-generation custom FSR solution for a leading robotic-assisted surgery platform.
• Continued expansion of presence as a trusted provider of printed electrode solutions in the healthcare diagnostics market.
• Added two Senior Business Development Directors in January 2026 to drive organic growth in North America and Europe.
• Successful conversion of preferred stock into common stock in October 2025, eliminating $400,000 of preferred stock dividends annually.
• Full-year 2025 revenue increased by 1.8% to $11.89 million compared to $11.68 million in 2024.
• Full-year 2025 net loss decreased to $1.615 million from $1.984 million in 2024, representing a $369,000 improvement.
• Full-year 2025 Adjusted EBITDA improved to $(885,000) from $(1.072) million in 2024, a $187,000 improvement.

Negatives

• Fourth-quarter 2025 revenue decreased 4.5% to $2.85 million, compared to $2.99 million in Q4 2024, driven by lower shipments of force-sensing products.
• Fourth-quarter 2025 gross profit decreased 23.5% to $905,000, compared to $1.183 million in Q4 2024.
• Fourth-quarter 2025 gross margin declined to 31.7% from 39.6% in Q4 2024, due to lower revenue, changes in product mix, and a strengthened Chinese yuan increasing production costs.
• Fourth-quarter 2025 net loss increased to $574,000, compared to a net loss of $413,000 in Q4 2024.
• Fourth-quarter 2025 Adjusted EBITDA was $(511,000), compared to $(233,000) in Q4 2024, indicating a larger negative EBITDA.
• Full-year 2025 gross profit decreased 4.5% to $4.630 million from $4.846 million in 2024.

Risks

• Success in predicting new markets and the acceptance of new products.
• Efficient management of infrastructure.
• The pace of technological developments and industry standards evolution and their effect on target product and market choices.
• The effect of outsourcing technology development.
• Changes in the ordering patterns of customers.
• A decrease in the quality and/or reliability of products.
• Protection of proprietary intellectual property.
• Competition by alternative sophisticated as well as generic products.
• Continued availability of raw materials for products at competitive prices.
• Disruptions in manufacturing facilities.
• Risks of international sales and operations, including fluctuations in exchange rates and tariffs.
• Compliance with regulatory requirements applicable to manufacturing operations.
• Customer concentrations.

Future Outlook

Interlink Electronics is confident in being well-positioned for organic growth in 2026 and 2027, driven by momentum with new and existing customers. The company is also actively pursuing acquisitions to further its growth strategy.

Management Comments

• Steven N. Bronson, Chairman, President, and CEO, stated: "We are excited about our momentum with both new and existing customers."
• Steven N. Bronson, Chairman, President, and CEO, stated: "We are confident that we are well-positioned for organic growth in 2026 and 2027."
• Steven N. Bronson, Chairman, President, and CEO, stated: "In addition, we are actively pursuing acquisitions."

Industry Context

StockSavvy.ai notes that Interlink Electronics' focus on custom sensor solutions for autonomous vehicles and robotic-assisted surgery aligns with high-growth segments within the broader technology and healthcare industries. The expansion into healthcare diagnostics also positions the company in a resilient market. While Q4 results show a dip, the strategic initiatives suggest an effort to capitalize on these industry trends, similar to how other sensor and electronics providers are diversifying into specialized, high-value applications.

Comparison to Industry Standards

• The deployment of a custom piezoelectric sensor in the autonomous vehicle market positions Interlink in a competitive space alongside companies like Velodyne Lidar and Luminar Technologies, which are also developing advanced sensing solutions for this sector. Interlink's focus on custom solutions suggests a niche strategy rather than direct competition with mass-market sensor producers.
• Shipping a second-generation FSR solution for robotic-assisted surgery platforms places Interlink in a market with high barriers to entry, competing indirectly with specialized component suppliers to major players like Intuitive Surgical. The 'second-generation' aspect implies continuous innovation, a key differentiator in medical technology.
• The decline in Q4 gross margin to 31.7% from 39.6% is below the average for many specialized electronics manufacturers, which often maintain gross margins in the 40-50% range, indicating potential cost pressures or unfavorable product mix compared to industry leaders.

Stakeholder Impact

• Shareholders: Positively impacted by the elimination of $400,000 in annual preferred stock dividends, which should improve earnings available to common stockholders. Mixed financial results for Q4, but improved annual losses and strategic growth initiatives could lead to future value creation.
• Employees: CEO and CFO received discretionary bonuses for their 2025 performance. Two Senior Business Development Directors were added in January 2026, indicating growth in the sales and business development teams.
• Customers: Benefit from new and second-generation sensor solutions being deployed in autonomous vehicles and robotic-assisted surgery, as well as continued expansion in healthcare diagnostics, indicating ongoing product development and support.
• Creditors: Financial performance, particularly the increased Q4 net loss and negative Adjusted EBITDA, could be a concern, though the reduction in annual losses offers some reassurance.

Next Steps

• Drive organic growth in North America and Europe through newly appointed Senior Business Development Directors.
• Actively pursue acquisitions to support strategic growth.
• Continue volume production of custom piezoelectric sensor solutions for autonomous vehicles.
• Continue shipping second-generation custom FSR solutions for robotic-assisted surgery platforms.
• Further expand presence in the healthcare diagnostics market with printed electrode solutions.

Key Dates

Recommendation

The Q4 2025 results show a concerning decline in revenue, gross profit, and an increased net loss, which typically warrants caution. However, the full-year results indicate an improvement in overall losses, and the company's strategic initiatives in high-growth sectors (autonomous vehicles, robotic surgery, healthcare diagnostics) along with the elimination of preferred stock dividends, suggest potential for future recovery and growth. A 'hold' recommendation allows investors to monitor if these strategic efforts translate into consistent positive financial performance in 2026 and 2027, as management anticipates, before making a more definitive investment decision.

Keywords

sensor technology, printed electronics, force-sensing resistors, piezoelectric sensors, autonomous vehicles, robotic surgery, healthcare diagnostics, Q4 2025 earnings, financial results, NASDAQ LINK